Onderneming Jiangsu Nhwa Pharmaceutical Co., LTD
Aandelen
002262
CNE100000CG8
Farmaceutische producten
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
25,01 CNY | -0,28% | +7,39% | -7,78% |
19/04 | Jiangsu Nhwa Pharmaceutical Co, LTD rapporteert resultaten voor het eerste kwartaal dat eindigde op 31 maart 2024 | CI |
03/04 | Nhwa Pharma krijgt goedkeuring om NH103 oxalaattabletten te testen | MT |
Vakgebied
Aantal werknemers: 5 394
Verkoop per activiteit
CNY in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Manufacturing
84,6
%
| 3 710 | 86,3 % | 4 263 | 84,6 % | +14,91% |
Commercial
14,5
%
| 523 | 12,2 % | 731 | 14,5 % | +39,77% |
Other
0,9
%
| 65 | 1,5 % | 47 | 0,9 % | -27,68% |
Verkoop per regio
CNY in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
China
99,8
%
| 4 282 | 99,6 % | 4 967 | 99,8 % | +15,99% |
International
0,2
%
| 16 | 0,4 % | 9 | 0,2 % | -46,00% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jia Quan Sun
CEO | Chief Executive Officer | 47 | 26-05-10 |
Gang Sheng Li
DFI | Director of Finance/CFO | 44 | 26-10-22 |
Zi Liang Yang
BRD | Director/Board Member | 60 | 23-04-07 |
Zeng Liang Chen
BRD | Director/Board Member | 61 | 23-04-07 |
Qing Fu
BRD | Director/Board Member | 62 | 23-04-07 |
Ji Ye Wu
IRC | Investor Relations Contact | - | - |
Bao Zhou Duan
SEC | Corporate Secretary | 57 | 25-09-08 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Peng Sheng Sun
CHM | Chairman | 65 | 23-04-07 |
Qing Fu
BRD | Director/Board Member | 62 | 23-04-07 |
Zeng Liang Chen
BRD | Director/Board Member | 61 | 23-04-07 |
Zi Liang Yang
BRD | Director/Board Member | 60 | 23-04-07 |
Xiao Xing Yin
BRD | Director/Board Member | 58 | 01-04-07 |
Feng Shou Wang
CHM | Chairman | 62 | 23-04-07 |
Xing Lei Jia
BRD | Director/Board Member | 55 | 23-04-07 |
Yu Lan Li
BRD | Director/Board Member | 73 | 22-05-13 |
Xiao Chen Qian
BRD | Director/Board Member | 61 | 22-05-13 |
Guo Xiang Chen
BRD | Director/Board Member | 59 | 29-04-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 1 007 588 092 | 485 535 871 ( 48,19 %) | 0 | 48,19 % |
Bedrijfsgegevens
Jiangsu Nhwa Pharmaceutical Co., Ltd.
Enhua Technology Building 31 Longhu West Road
221009, Xuzhou
+
http://www.nhwa-group.comSector
Verkoop per activiteit
Verkoop per regio
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-7,78% | 3,48 mld. | |
+29,68% | 699 mld. | |
+25,07% | 571 mld. | |
-4,35% | 364 mld. | |
+17,65% | 326 mld. | |
+3,77% | 286 mld. | |
+14,68% | 236 mld. | |
+4,71% | 198 mld. | |
-12,43% | 194 mld. | |
-3,79% | 154 mld. |
- Beurs
- Aandelen
- Koers 002262
- Onderneming Jiangsu Nhwa Pharmaceutical Co., LTD